This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Colestipol hydrochloride

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20220804

Version

3

Spl Product Data Elements

Colestipol hydrochloride Colestipol hydrochloride COLESTIPOL HYDROCHLORIDE COLESTIPOL CELLACEFATE CELLULOSE, MICROCRYSTALLINE CROSPOVIDONE (120 .MU.M) FERRIC OXIDE YELLOW HYPROMELLOSE 2910 (15 MPA.S) HYPROMELLOSE 2910 (5 MPA.S) HYPROMELLOSE 2910 (6 MPA.S) MAGNESIUM STEARATE POLYVINYL ALCOHOL, UNSPECIFIED POVIDONE K90 SILICON DIOXIDE TRIACETIN light yellow to yellow CZ

Application Number

ANDA215223

Brand Name

Colestipol hydrochloride

Generic Name

Colestipol hydrochloride

Product Ndc

70771-1653

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Colestipol hydrochloride tablets, 1 g 120 tablets NDC 70771-1653-7 Rx only label

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.